The history of Viagra, initially marketed by copyright, presents a fascinating case study for backers considering the pharmaceutical sector. While its initial success and impact of countless in revenue , the exclusivity end has opened the floodgates for alternative medications, substantially reducing profit potential . This shift raises doubts abou